Stay updated with breaking news from Condition Event. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") today announced the publication of updated results from an evaluation...
/PRNewswire/ -- BioArctic AB's (publ) (NASDAQ Stockholm: BIOA B) partner Eisai today announced the publication of updated results from an evaluation estimating...
Second Publication on the Potential Value of Lecanemab in Patients with Early Alzheimer's Disease Using Simulation ModelingTOKYO, June 22, 2022 - (JCN Newswire) - Eisai Co., Ltd. today announced publication